BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28377036)

  • 1. Regression Patterns of Iris Melanoma after Palladium-103 (
    Chaugule SS; Finger PT
    Ophthalmology; 2017 Jul; 124(7):1023-1030. PubMed ID: 28377036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression patterns of choroidal melanoma: After palladium-103 (
    Maheshwari A; Finger PT
    Eur J Ophthalmol; 2018 Nov; 28(6):722-730. PubMed ID: 29788760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of radiation maculopathy after palladium-103 plaque radiotherapy for iris melanoma.
    Yousef YA; Finger PT
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1107-12. PubMed ID: 22172910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plaque radiation therapy for malignant melanoma of the iris and ciliary body.
    Finger PT
    Am J Ophthalmol; 2001 Sep; 132(3):328-35. PubMed ID: 11530044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients.
    Finger PT; Chin KJ; Duvall G;
    Ophthalmology; 2009 Apr; 116(4):790-6, 796.e1. PubMed ID: 19243829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palladium-103 plaque radiation therapy for American Joint Committee on cancer T3- and T4-staged choroidal melanomas.
    Semenova E; Finger PT
    JAMA Ophthalmol; 2014 Feb; 132(2):205-13. PubMed ID: 24287555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plaque radiotherapy for residual or recurrent iris melanoma after surgical resection in 32 cases.
    Shah SU; Shields CL; Bianciotto C; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2012 Apr; 119(4):838-842.e2. PubMed ID: 22133794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A five-year study of slotted eye plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve.
    Finger PT; Chin KJ; Tena LB
    Ophthalmology; 2012 Feb; 119(2):415-22. PubMed ID: 22133796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 12-Year Study of Slotted Palladium-103 Plaque Radiation Therapy for Choroidal Melanoma: Near, Touching, or Surrounding the Optic Nerve.
    Maheshwari A; Finger PT
    Am J Ophthalmol; 2018 Apr; 188():60-69. PubMed ID: 29409899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palladium-103 plaque therapy for multifocal iris melanoma: Radiation of the entire anterior segment of the eye.
    Finger PT; Tomar AS; Chin KJ
    Eur J Ophthalmol; 2021 May; 31(3):1375-1383. PubMed ID: 32306746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes.
    Shields CL; Shah SU; Bianciotto CG; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2013 Jan; 120(1):55-61. PubMed ID: 22980742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications.
    Shields CL; Naseripour M; Shields JA; Freire J; Cater J
    Am J Ophthalmol; 2003 May; 135(5):648-56. PubMed ID: 12719072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifocal iris melanoma treated with total anterior segment palladium-103 plaque radiation therapy.
    Petousis V; Finger PT; Milman T
    Graefes Arch Clin Exp Ophthalmol; 2011 Jun; 249(6):937-40. PubMed ID: 21222214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palladium-103 radiation therapy for small choroidal melanoma.
    Semenova E; Finger PT
    Ophthalmology; 2013 Nov; 120(11):2353-7. PubMed ID: 23774104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Ruthenium-106 Brachytherapy for Iris Melanoma: The Scottish Experience.
    Agraval U; Sobti M; Russell HC; Lockington D; Ritchie D; Cauchi P; Kemp EG; Chadha V
    Br J Ophthalmol; 2018 Jan; 102(1):74-78. PubMed ID: 28600302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study.
    Finger PT; Berson A; Szechter A
    Ophthalmology; 1999 Mar; 106(3):606-13. PubMed ID: 10080222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
    Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
    Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-frequency ultrasound characteristics of 24 iris and iridociliary melanomas: before and after plaque brachytherapy.
    Finger PT; Reddy S; Chin K
    Arch Ophthalmol; 2007 Aug; 125(8):1051-8. PubMed ID: 17698751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual acuity, oncologic, and toxicity outcomes with
    Patel KR; Prabhu RS; Switchenko JM; Chowdhary M; Craven C; Mendoza P; Danish H; Grossniklaus HE; Aaberg TM; Aaberg T; Reddy S; Butker E; Bergstrom C; Crocker IR
    Brachytherapy; 2017; 16(3):646-653. PubMed ID: 28262517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral simultaneous primary choroidal melanomas: Treated with palladium-103 plaque radiation.
    Maheshwari A; Finger PT
    Eur J Ophthalmol; 2018 Sep; 28(5):NP1-NP5. PubMed ID: 29575936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.